Literature DB >> 26301929

Generation and Characterization of Murine Monoclonal Antibodies anti-PBP2a of Methicillin-resistant Staphylococcus aureus.

José Procópio M Senna1, Maria da Glória M Teixeira1, Marta de A Santiago1, Nádia M Batoréu1, Napoleão Valadares2,3, Ricardo Galler1.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a multidrug-resistant bacterium that causes serious infections worldwide. This pathogen is resistant to all beta lactam antibiotics due the presence of PBP2a, a transpeptidase enzyme that presents very low beta-lactam affinity. Here we report the generation and characterization of mouse monoclonal antibodies to PBP2a of MRSA strains. Two clones were obtained and characterized by immunoassays (ELISA, avidity index determination, and immunoblotting), isotyping, association/dissociation rate constants by surface plasmon resonance (SPR), and flow cytometry. Clone 38, which showed the best avidity and affinity, bound to PBP2a located on the bacterial surface by flow cytometry. Further studies are warranted in order to evaluate if these antibodies may help inhibit bacterial growth and be used to treat infections by MRSA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26301929     DOI: 10.1089/mab.2015.0013

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN: 2167-9436


  2 in total

Review 1.  Antibody-Based Agents in the Management of Antibiotic-Resistant Staphylococcus aureus Diseases.

Authors:  Pietro Speziale; Simonetta Rindi; Giampiero Pietrocola
Journal:  Microorganisms       Date:  2018-03-13

2.  Monoclonal antibody anti-PBP2a protects mice against MRSA (methicillin-resistant Staphylococcus aureus) infections.

Authors:  Felipe Betoni Saraiva; Ana Caroline Cavalcante de Araújo; Anna Érika Vieira de Araújo; José Procópio Moreno Senna
Journal:  PLoS One       Date:  2019-11-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.